Back to Search
SCOTT GREENSPAN, MD
MD
Family Medicine Physician
NPI: 1427049071Individual
Specialties, Licenses & Credentials
Family Medicine PhysicianPrimary
Family Medicine
Code: 207Q00000X
G53125(CA)
Research & Publications (20)
Approach to the prostate cancer patient with bone disease.
PMID 18178905·J Clin Endocrinol Metab·2008
5-case
The interdisciplinary council on developmental and learning disorders diagnostic manual for infants and young children - an overview.
PMID 18516310·J Can Acad Child Adolesc Psychiatry·2008
8-other
Bone loss after initiation of androgen deprivation therapy in patients with prostate cancer.
PMID 16189261·J Clin Endocrinol Metab·2005
8-other
Combination therapy with hormone replacement and alendronate for prevention of bone loss in elderly women: a randomized controlled trial.
PMID 12759324·JAMA·2003
3-trial
Tolerability of once-weekly alendronate in patients with osteoporosis: a randomized, double-blind, placebo-controlled study.
PMID 12374248·Mayo Clin Proc·2002
3-trial
Significant differential effects of alendronate, estrogen, or combination therapy on the rate of bone loss after discontinuation of treatment of postmenopausal osteoporosis. A randomized, double-blind, placebo-controlled trial.
PMID 12458987·Ann Intern Med·2002
3-trial
Instant vertebral assessment: a noninvasive dual X-ray absorptiometry technique to avoid misclassification and clinical mismanagement of osteoporosis.
PMID 11748342·J Clin Densitom·2001
8-other
Clinical performance of a highly portable, scanning calcaneal ultrasonometer.
PMID 11444088·Osteoporos Int·2001
8-other
Early changes in serum N-telopeptide and C-telopeptide cross-linked collagen type 1 predict long-term response to alendronate therapy in elderly women.
PMID 11061497·J Clin Endocrinol Metab·2000
3-trial
Prediction of changes in bone mineral density in postmenopausal women treated with once-weekly bisphosphonates.
PMID 19141590·J Clin Endocrinol Metab·2009
8-other
Factors associated with diagnosis and treatment of osteoporosis in older adults.
PMID 19151910·Osteoporos Int·2009
8-other
The Global Longitudinal Study of Osteoporosis in Women (GLOW): rationale and study design.
PMID 19468663·Osteoporos Int·2009
4-observational
Factors associated with osteoporosis screening and recommendations for osteoporosis screening in older adults.
PMID 19274478·J Gen Intern Med·2009
4-observational
Assessment and diagnosis of mental retardation in death penalty cases: introduction and overview of the special "Atkins" issue.
PMID 19430989·Appl Neuropsychol·2009
8-other
Early responsiveness of women with osteoporosis to teriparatide after therapy with alendronate or risedronate.
PMID 18682511·J Clin Endocrinol Metab·2008
2-rct
Skeletal health after continuation, withdrawal, or delay of alendronate in men with prostate cancer undergoing androgen-deprivation therapy.
PMID 18802155·J Clin Oncol·2008
2-rct
Body composition changes during androgen deprivation therapy for prostate cancer: a 2-year prospective study.
PMID 18706829·Crit Rev Oncol Hematol·2008
3-trial
Femoral bone strength and its relation to cortical and trabecular changes after treatment with PTH, alendronate, and their combination as assessed by finite element analysis of quantitative CT scans.
PMID 18684084·J Bone Miner Res·2008
4-observational
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 31001 RANCHO VIEJO RD, SUITE 200
SAN JUAN CAPISTRANO, CA 92675 - Phone
- (949) 661-9611
Quick Facts
- NPI
- 1427049071
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile